Becker Daniel J.
Insider CIK 1752139 · PRNB Director, 10% owner · PAND Director, 10% owner · DAWN Director · ZURA Director · SLRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZURA Zura Bio Ltd | A Award deriv | 2026-06-17 | 2026-06-22 | 51,000 | — | $0 | 51,000 | SEC↗ |
| ZURA Zura Bio Ltd | A Award deriv | 2025-05-29 | 2025-05-29 | 51,000 | — | $0 | 51,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer deriv | 2025-05-21 | 2025-05-23 | 92,158 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | D To issuer | 2025-05-21 | 2025-05-23 | 2,999 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | S Sale | 2024-07-17 | 2024-07-19 | 1 | $6.86 | $7 | 2,999 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 92,158 | — | $0 | 92,158 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2023-06-22 | 2023-06-26 | 37,500 | — | $0 | 37,500 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 23,243 | SEC↗ |
| SLRN ACELYRIN, Inc. | J Other deriv | 2023-05-09 | 2023-05-11 | 23,243 | — | $0 | 0 | SEC↗ |
| SLRN ACELYRIN, Inc. | P Buy | 2023-05-09 | 2023-05-11 | 3,000 | $18.00 | $54.0K | 3,000 | SEC↗ |
| SLRN ACELYRIN, Inc. | A Award deriv | 2023-05-04 | 2023-05-04 | 23,243 | — | $0 | 23,243 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2022-06-21 | 2022-06-23 | 28,700 | — | $0 | 28,700 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2021-06-01 | 2021-06-01 | 5,000 | $16.00 | $80.0K | 5,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2021-05-26 | 2021-06-01 | 63,000 | — | $0 | 63,000 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 13,997 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 1,000 | $60.00 | $60.0K | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 2,827,883 | $60.00 | $169.67M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-11-19 | 2020-11-23 | 197,716 | $15.12 | $2.99M | 2,827,883 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-11-18 | 2020-11-19 | 14,197 | $15.26 | $216.6K | 2,630,167 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-11-17 | 2020-11-19 | 13,027 | $15.43 | $201.0K | 2,615,970 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-11-17 | 2020-11-19 | 2,170 | $14.63 | $31.7K | 2,602,943 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 10,240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 10,240 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 20,475 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 667,600 | $100.00 | $66.76M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 9,579,462 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 722,222 | $18.00 | $13.00M | 2,600,773 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 1,000 | $18.00 | $18.0K | 1,000 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 1,878,551 | — | $0 | 1,878,551 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 13,997 | — | $0 | 13,997 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 10,240 | — | $0 | 10,240 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2019-11-20 | 2019-11-22 | 55,000 | $29.94 | $1.65M | 667,600 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2019-10-29 | 2019-10-30 | 9,196 | $33.98 | $312.5K | 612,600 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2019-10-28 | 2019-10-30 | 68,404 | $33.41 | $2.29M | 603,404 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2019-10-18 | 2019-10-22 | 535,000 | $28.00 | $14.98M | 535,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-06-11 | 2019-06-11 | 10,240 | — | $0 | 10,240 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 1,070,771 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 544,047 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 260,617 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 312,741 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 167,537 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 260,617 | — | $0 | 1,644,129 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 270,000 | $17.00 | $4.59M | 437,537 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 544,047 | — | $0 | 2,188,176 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 1,070,771 | — | $0 | 1,070,771 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 312,741 | — | $0 | 1,383,512 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2018-09-13 | 2019-01-10 | 20,475 | — | $0 | 20,475 | SEC↗ |